Rahmer Peter's Form 4 filing
Relay Therapeutics, Inc. (RLAY) · filed Oct 30, 2025
- Accession no.
- 0001193125-25-258595
- Filed
- Oct 30, 2025
- Trade date
- Oct 28-29, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $299.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rahmer PeterCIK 0001959229 | Officer (See remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 28, 2025 | Common Stock | SSaleDisposed | −19,135 | $7.29 | −$139,494.15 | 358,863 | Direct | |
| Oct 29, 2025 | Common Stock | SSaleDisposed | −21,394 | $7.50 | −$160,455 | 337,469 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.